A trio of warning letters, some analysis and advice related to the discovery of nitrosamine impurities in various medications, and a clarification by one of the US presidential candidates on her plan for public-sector pharmaceutical manufacturing are featured in this latest edition of the Quality Lowdown.
The warning letters to over-the-counter drug manufacturers on three continents highlighted comparable types of failures in basic drug good manufacturing...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?